Breaking News
Close
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Dynavax Technologies Corporation (DVAX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Dynavax's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.165 +0.485    +4.15%
17:17:07 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 1,494,218
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 11.570 - 12.295
Type:  Equity
Market:  United States
ISIN:  US2681582019 
CUSIP:  268158201
Dynavax 12.165 +0.485 +4.15%

For the three months ended 31 March 2022, Dynavax Technologies Corporation revenues increased 37% to $114M. Net income increased from $891K to $32.9M. Revenues reflect CpG 1018 segment increase from $21.9M to $91.5M, HEPLISAV-B segment increase from $2.7M to $20.8M. Net income benefited from Change in fair value of warrant liabilit increase from $25.6M (expense) to $1.8M (income), Interest expense decrease of 64% to $1.7M (expense).

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

DVAX Income Statement

Gross margin TTM 59.82%
Operating margin TTM 27.97%
Net Profit margin TTM 23.12%
Return on Investment TTM 23.54%
 Total Revenue  Net Income
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Revenue 113.99 195.07 108.27 52.77
Gross Profit 74.03 121.06 48.18 37.92
Operating Income 30.76 80.72 16.07 3.94
Net Income 32.86 99.78 -28.43 4.47

DVAX Balance Sheet

Quick Ratio MRQ 1.85
Current Ratio MRQ 2.02
LT Debt to Equity MRQ 76.79%
Total Debt to Equity MRQ 76.79%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Assets 1008.98 1039.25 919.71 647.91
Total Liabilities 721.49 816.87 852.13 564.53
Total Equity 287.48 222.37 67.58 83.38

DVAX Cash Flow Statement

Cash Flow/Share TTM 0.79
Revenue/Share TTM 3.28
Operating Cash Flow  -10.82%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Period Length: 3 Months 12 Months 9 Months 6 Months
Cash From Operating Activities -50.44 335.53 215.03 148.82
Cash From Investing Activities -216.48 14.22 -40.71 -86.39
Cash From Financing Activities 10.29 55.78 40.96 35.64
Net Change in Cash -256.77 404.1 214.26 97.53
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DVAX Comments

Write your thoughts about Dynavax Technologies Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Roy Martinez
Roy Martinez Sep 23, 2021 2:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sold at $18,60 with nice $10 gain Will buy back if there is the anticipated market correction later this year.Believe stock could easily reach $25 plus when looking at its Financials and Drug research/production.
Joohan Tan
Joohan Tan Aug 11, 2021 14:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30 once covid 19 vaccine success
Roy Martinez
Roy Martinez Aug 11, 2021 14:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hope so; still looking good after buying at $7,25
Marvin Lawrence
Marvin Lawrence Feb 01, 2021 19:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big year for DVAX, numerous contracts signed, expecting to hit past the 20s soon
Marvin Lawrence
Marvin Lawrence Feb 01, 2021 19:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big year for DVAX, numerous contracts signed
Roy Martinez
Roy Martinez Jul 25, 2020 8:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Got out at $9.7 with 100% profit. May buy again if price sinks further but a volatile ride.
Avatar Bond
Avatar Bond Jul 25, 2020 8:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now this will be on the rise...earnings coming next week and will rocket!
Avatar Bond
Avatar Bond Jul 16, 2020 14:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whoever thinks this will rocket hit like button!
Saeed Ahmed
Saeed Ahmed Jul 02, 2020 2:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There Hep B Vaccine will produce revenue if they don't find a vaccine for covid 19
Rishabh Dhivare
Rishabh Dhivare Jul 02, 2020 2:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
As of today India anounced the vaccine for COVID-19,
Saeed Ahmed
Saeed Ahmed Jul 02, 2020 2:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes but India's process of getting a vaccine into the market is different there is less red tape and less regulations to follow.
Roy Martinez
Roy Martinez Jul 02, 2020 2:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes but their revenue recent results were very poor !
Avatar Bond
Avatar Bond Jun 24, 2020 13:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bright future!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email